Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (24104)	8/6/1998 6:23:00 PM
From: medsunman	Read Replies (1) \| Respond to of 32384

Henry: Here is some interesting info I came across in today issue of BioWorld Today: "Today, Kaposi's sarcoma (KS) is ... the leading form of cancer that strikes Americans with AIDS. ... Aids patients do not usually die because of KS. Most of them develop this cancer at the terminal stage of their disease. Thirty percent or more have the tumor, but they die most often of other diseases. ... Kaposi's sarcoma, the commonest malignancy for HIV-infected people, is a growing public health problem as AIDS sufferers are surviving longer and are more vulnerable to cancer during the later stages of their disease."